Riskpilot← Back to searchSign inGet full accessSallakliniken AB
ABActiveOrg 5591807788Älvgatan 40Other human health activities n.e.c. · NACE 8699Est. 20185 employees
Revenue 2025
SEK 14,2M
+24% vs 2024
EBITDA margin
15.1%
+10% vs 2024
Equity ratio
47.5%
Financial strength
Net profit 2025
SEK 1,6M
+14% vs 2024
| Revenue | SEK 14,2M | +24% |
| EBITDA | SEK 2,2M | +10% |
| Net profit | SEK 1,6M | +14% |
| Total assets | SEK 5,3M | +60% |
| Equity | SEK 2,5M | +50% |
| Employees | 5 | — |
Legal name
Sallakliniken AB
Org number
5591807788
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
19 november 2018
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva tandvårdsverksamhet, äga och förvalta värdepapper samt annan därmed förenlig verksamhet.
Address
Älvgatan 40
Email
info@sallakliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 602 | 6 577 | 6 598 | 11 469 | 14 249 |
| Staff expenses | — | −3 610 | −3 339 | −3 080 | −3 791 |
| EBITDA | 1 500 | 693 | 524 | 1 958 | 2 154 |
| Depreciation & amort. | −259 | −294 | −316 | −148 | −88 |
| EBIT | 1 241 | 400 | 208 | 1 810 | 2 066 |
| Net financials | −2 | −2 | 1 | 2 | 1 |
| Profit before tax | 1 240 | 398 | 209 | 1 813 | 2 067 |
| Tax | −270 | −89 | −39 | −380 | −431 |
| Net profit | 970 | 309 | 170 | 1 433 | 1 636 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 468 | 1 784 | 1 504 | 3 306 | 5 291 |
| Equity | 1 114 | 623 | 493 | 1 675 | 2 511 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 1 354 | 1 161 | 1 011 | 1 630 | 2 780 |
| Total debt | 1 354 | 1 161 | 1 011 | 1 630 | 2 780 |
EBITDA margin
15.1%
This company
15.8%
Market median
+4% vs market
20212025
Equity ratio
47.5%
This company
38.2%
Market median
+24% vs market
20212025
Return on equity
65.1%
This company
18.4%
Market median
+254% vs market
20212025
Net profit margin
11.5%
This company
8.1%
Market median
+42% vs market
20212025
Asset turnover
2.69×
This company
1.12×
Market median
+140% vs market
20212025
Debt / equity
1.11×
This company
0.62×
Market median
-79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JJ | Audit | 2025 |
| Former (2) | ||
SQ Audit | Audit | 2022 – 2022 |
OB | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sallakliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefan Quinn Backman | Audit | 0 companies |
| Jonas Joakim Läckström | Audit | 0 companies |
| Olof Björn Christer Elfgren | Audit | 0 companies |
| Elisabeth Maria Persson | Board of Directors | 0 companies |
| Per-Inge Kenneth Karlsson | Deputy Board Member | 0 companies |
| Inger Marita Karlsson | Chairman | 0 companies |
| Anders Richard Persson | Deputy Board Member | 0 companies |